|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
12 December 2020 |
|
Main ID: |
NCT02311387 |
|
Date of registration:
|
05/12/2014 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
Seroprevalence and Incidence of Lassa Fever in the Rural Commune of Sibirila, District of Bougouni, Mali
|
|
Scientific title:
|
Study of the Seroprevalence and the Incidence of Lassa Fever in the Rural Commune of Sibirila, District of Bougouni, Mali |
|
Date of first enrolment:
|
December 5, 2014 |
|
Target sample size:
|
601 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/show/NCT02311387 |
|
Study type:
|
Observational |
|
Study design:
|
|
|
Phase:
|
|
|
|
Countries of recruitment
|
|
Mali
| | | | | | | |
|
Contacts
|
|
Name:
|
Heinrich U Feldmann, M.D. |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
National Institute of Allergy and Infectious Diseases (NIAID) |
| | |
|
Key inclusion & exclusion criteria
|
- INCLUSION CRITERIA:
- Age greater than or equal to 6 months.
- Resident of Soromba, Bamba or Banzana with no plans to relocate within 1 year.
EXCLUSION CRITERIA:
- Any condition that in the opinion of the investigator would render the participant
unable to comply with the protocol (e.g., psychiatric disease).
- Any health condition that would confound data analysis or pose unnecessary exposure
risks to study personnel in the opinion of the investigator.
Age minimum:
6 Months
Age maximum:
N/A
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Lassa Virus Infection
|
|
Primary Outcome(s)
|
|
To determine the annual incidence of seroconversion due to Lassa virus infection. Prevalence of Lassa virus exposure at the start of the study will be compared to the prevalence at the end of one calendar year to determine the one year incidence...
[Time Frame: One year after study start date.]
|
|
To determine the seroprevalence of Lassa virus infection in the population of Southern Mali at the study start date. The prevalence of Lassa virus infection will be based on serological evidence in the villages of Soromba, Bamba and Banzana.
[Time Frame: At time of study start.]
|
|
To determine the proportion of individuals in these villages who haveexperienced symptoms consistent with Lassa fever at the start of the study
[Time Frame: At time of study start.]
|
|
Secondary ID(s)
|
|
15-I-N023
|
|
999915023
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|